The first report of the immune dynamics during mild COVID-19 demonstrated that in a single patient the number of circulating CD8+ T-cells (CD38+ HLA-DR+) and antibody secreting B cells increased early in disease, peaking 8 to 9 days after symptom onset. This evidence concerns the gene CD8A and COVID-19.